After Biogen failed with a takeover bid in January, Supernus has swooped in to buy the postpartum depression pill developer.

MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...

Ethris has entered a strategic partnership with Thermo Fisher Scientific for providing completely integrated mRNA solution.

Surovatamig shows promise, but needs to outperform established therapies such as Blincyto and Aucatzyl.

Shares in both companies were down following news of the second death, casting fresh safety concerns over Elevidys.

Lynozyfic’s global sales are projected to reach $707 million by 2031.

The label expansion for Moderna’s jab arrives at a juncture in America’s changing vaccine regulatory landscape.

The US Food and Drug Administration (FDA) has approved the label expansion of AbbVie’s Mavyret (glecaprevir/pibrentasvir).

GSK has licensed altSonflex1-2-3, its Shigella vaccine candidate, to Bharat Biotech for the continued development and ...

Deep Apple is the latest biotech to be tapped by Novo Nordisk as the drugmaker aims to regain market share lost to Eli Lilly.

AstraZeneca is the latest pharma company enlisting the services of Chinese biotechs, signing a deal worth up to $5.2bn with ...

The 17 sitting members of the Advisory Committee on Immunization Practices (ACIP) will be replaced by new members chosen by ...